The proportion of males in the MetS-CRP-, MetS-CRP + , MetS + CRP-, and MetS + CRP + groups was 82.55%, 83.12%, 56.33%, and 46.28%, respectively. This evidence concerns the gene CRP and metabolic syndrome.